+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pharmaceutical Market Access"

From
From
From
Peptide And Oligonucleotide CDMO Global Market Report 2024 - Product Thumbnail Image

Peptide And Oligonucleotide CDMO Global Market Report 2024

  • Report
  • July 2024
  • 175 Pages
  • Global
From
From
From
From
From
From
From
The Pharma Mini MBA Training Course (November 5-7, 2025) - Product Thumbnail Image

The Pharma Mini MBA Training Course (November 5-7, 2025)

  • Conference
  • November 2025
  • 3 Days
  • Global
The Pharma Mini MBA Training Course (July 9-11, 2025) - Product Thumbnail Image

The Pharma Mini MBA Training Course (July 9-11, 2025)

  • Conference
  • July 2025
  • 3 Days
  • Global
GCC Pharmaceutical Market Opportunity & Clinical Trials Outlook 2030 - Product Thumbnail Image

GCC Pharmaceutical Market Opportunity & Clinical Trials Outlook 2030

  • Report
  • December 2024
  • 840 Pages
  • Middle East
From
Loading Indicator

The Pharmaceutical Market Access market is a sector of the pharmaceutical industry that focuses on the commercialization of drugs and other healthcare products. It involves the development of strategies to ensure that products are available to patients and healthcare providers in a timely and cost-effective manner. This includes activities such as pricing, reimbursement, distribution, and promotion. Market access teams work to ensure that products are available to the right patients, at the right time, and at the right price. Companies in the Pharmaceutical Market Access market include AbbVie, AstraZeneca, Bayer, Boehringer Ingelheim, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more